Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...

Background and objectives Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer.

The stage of prostate cancer tells you how far it has spread. TNM is a way of staging prostate cancer. It stands for Tumour, Node and Metastasis. Doctors in the UK now use a tool called the Cambridge ...

We used each method to select PLCO intervention-group participants and determined the classification accuracies for selecting persons who receive a diagnosis of lung cancer in 6 years of follow-up.

There are two main types of lung cancer: non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Several subtypes exist within these categories, and there are a few other ...

"While the overall survival rates for patients with non-small cell lung cancer have significantly improved in recent years, lung cancer continues to be the leading cause of cancer death worldwide ...

We conducted a randomized trial of prophylactic cranial irradiation in patients with extensive small-cell lung cancer who had had ... was not part of standard staging and follow-up procedures ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

Eligible patients with previously untreated, metastatic squamous non–small-cell lung cancer (NSCLC) were randomly assigned 1:1 to pembrolizumab 200 mg or placebo plus carboplatin and ...

In the UK, doctors now use the Cambridge Prognostic Group (CPG) for prostate cancer that hasn't spread. This divides prostate cancer into 5 prognostic groups. The term prognostic refers to your ...